 WEST CHESTER, Pa., Aug. 31, 2022 GLOBE NEWSWIRE -- Verrica Pharmaceuticals Inc. Verrica Nasdaq: VRCA, a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022 at 3:30 p.m. ET. 